NeuroSearch to Acquire Carlsson Research
The Danish publicly listed biopharmaceutical company NeuroSearch A/S has signed a conditional agreement to acquire A. Carlsson Research AB – one of Sweden’s leading biopharmaceutical companies within discovery and development of drugs for the treatment of diseases in the central nervous system (CNS). The agreed consideration amounts to SEK 875 million whereof SEK 250 million is to be paid upfront and SEK 625 million is to be paid in connection with the successful attainment of agreed development milestones.“Since inception, we have proven our ability to efficiently generate truly novel